Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 5/20 | 0.41 |
| ▸ | CCR2 | P41597 | 2/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.40 |
| ▸ | BCHE | P06276 | 3/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | DRD4 | P21917 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL4606076 | 0.89 | KCNH2 (0.46) | KCNH2MEN1KMT2ASLC2A1 | |
| Trifluoroacetic Acid SCHEMBL4159827 | 0.87 | BCHE (0.42) | ACHECCR2BCHEKCNH2MEN1 | |
| Trifluoroacetic Acid SCHEMBL4164046 | 0.86 | SLC2A1 (0.40) | KCNH2MEN1KMT2ASLC2A1 | |
| Trifluoroacetic Acid SCHEMBL4156616 | 0.85 | CHRM4 (0.41) | ACHECCR2CHRM4BCHEKCNH2 | |
| Trifluoroacetic Acid SCHEMBL4166752 | 0.85 | KCNH2 (0.39) | KCNH2SLC2A1 | |
| Trifluoroacetic Acid SCHEMBL4161040 | 0.84 | SIGMAR1 (0.43) | KCNH2SLC2A1DRD2DRD4 | |
| Trifluoroacetic Acid SCHEMBL4171441 | 0.83 | CHRM3 (0.42) | ACHELMNA | |
| Trifluoroacetic Acid SCHEMBL4154008 | 0.82 | CHRM2 (0.38) | CHRM4KCNH2LMNASLC2A1 | |
| Trifluoroacetic Acid SCHEMBL4622705 | 0.80 | ALDH1A1 (0.39) | — | |
| Trifluoroacetic Acid SCHEMBL4158032 | 0.80 | ALDH1A1 (0.36) | CCR2LMNAKMT2ADRD2DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090054448-A1 | Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors | JONES PHILIP | 2009-02-26 | — | — | US | disclosed |
| EP-1945609-A2 | AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) | 2008-07-23 | — | — | EP | disclosed |
| WO-2007029036-A2 | AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) | 2007-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054448-A1 | Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors | HDAC5, HDAC1, HDAC11 | ACHE 2183/4885CCR2 3695/4885CHRM4 4732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.